Huawei Xin

2.2k citations
29 papers · 1.7k indexed · h-index 16
Topics
Telomeres, Telomerase, and Senescence (6 papers)Ginkgo biloba and Cashew Applications (4 papers)Neurological Disease Mechanisms and Treatments (4 papers)
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Huawei Xin

27 papers receiving 1.7k citations

Peers

Huawei Xin
Comparison fields: 5 of 110
  • Molecular Biology 1.2k
  • Physiology 748
  • Aging 151
  • Plant Science 141
  • Genetics 92
Replace Li Xu with:
Li Xu China
Elizabeth Langley Mexico
Yuqing Dong China
Carmen E. Perrone United States
Hye‐Yeon Lee South Korea
Joung‐Woo Hong South Korea
Andrea Vasconsuelo Argentina
Hitoshi Endo Japan
Norbert Naß Germany
Huiping Ma China
Huawei Xin relative to Li Xu China Li Xu's profile →
Citations per field
00.5×1.5×2.3×
Li Xu · 1×
Citations per year

Countries citing papers authored by Huawei Xin

Since Specialization
Citations

This map shows the geographic impact of Huawei Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Xin more than expected).

Fields of papers citing papers by Huawei Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huawei Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Xin. The network helps show where Huawei Xin may publish in the future.

Co-authorship network of co-authors of Huawei Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Huawei Xin. A scholar is included among the top collaborators of Huawei Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huawei Xin. Huawei Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 26
4 48
5 73
6 28
7 29
8 9
9 8
10 3
11 7
12 51
13 9
14 105
15
LCA3, A Novel Early Onset Retinal Disease Gene, Functions in Protein Transport Vesicles
1
16 165
17 348
18 367
19 49
20 53

About Huawei Xin

Huawei Xin is a scholar working on Complementary and alternative medicine, Neurology and Physiology, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (6 papers), Ginkgo biloba and Cashew Applications (4 papers) and Neurological Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Aging (151 citations), Physiology (748 citations) and Molecular Biology (1.2k citations). Huawei Xin has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhou Songyang, Dan Liu, Matthew S. O’Connor, Ma Wan, Hyeung Kim, Dan Liu, Wen Sun, Yulei Cui, Jun Qin and Jiemin Wong. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026